FINWIRES · TerminalLIVE
FINWIRES

Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says

By

Charles River Laboratories (CRL) has the potential to outperform expectations in the second half of 2026, RBC Capital Markets analysts said in a Thursday note.

Analysts said that the company's "Pathways to Purpose" strategy is positioning it to capitalize on improving biotech funding and pharma investment in research and development.

RBC said that the company sees various opportunities, including in China, New Alternative Methods, and organic market share gains from a recent competitor's bankruptcy.

"We expect strong biopharma funding to continue in 2026 which combined with healthy cash runways should manifest in accelerated preclinical R&D spending growth in 2026 and into 2027," analysts said.

RBC has an outperform rating and a $215 price target on the stock.

Price: $184.94, Change: $-0.85, Percent Change: -0.46%

Related Articles

Wire

Ainsworth Game Technology Chair Resigns; Shares Hit Over Eight-Year High

Ainsworth Game Technology (ASX:AGI) said that Non-Executive Chair Danny Gladstone has resigned with immediate effect following recent media reports concerning personal payments made to him more than eight years ago, according to a Friday filing with the Australian bourse.Gladstone said his resignation was intended to serve the company's best interests by allowing it to move beyond the distraction and focus on its strategic priorities, per the filing.Graeme Campbell has been appointed chair of the board, the filing added.The company's shares rose around 10% in recent Friday trade and earlier hit their highest level since April 2018.

$ASX:AGI
Wire

Wealthfront Fiscal Q1 Earnings Fall, Revenue Rises

Wealthfront (WLTH) reported fiscal Q1 earnings late Thursday of $0.07 per diluted share, down from $0.18 a year earlier.Analysts polled by FactSet expected EPS of $0.12.Revenue for the quarter ended April 30 was $90.5 million, up from $84.5 million a year earlier.Analysts expected $91.8 million.Shares of Wealthfront were down roughly 9% in after-hours activity.

$WLTH
Wire

Samsara Fiscal Q1 Non-GAAP Earnings, Revenue Rise; Shares Fall After Hours

Samsara (IOT) reported fiscal Q1 non-GAAP earnings late Thursday of $0.17 per diluted share, up from $0.11 a year earlier.Analysts polled by FactSet expected $0.13.Revenue in the three months ended May 2 rose to $478.8 million from $366.9 million a year earlier.Analysts expected $455.2 million.Samsara expects Q2 adjusted EPS of $0.15 to $0.16 on revenue of $482 million to $484 million.Analysts project EPS of $0.15 on revenue of $480.1 million.The company expects full-year adjusted EPS of $0.70 to $0.72 on revenue of $2.005 billion to $2.03 billion. Analysts project EPS of $0.68 on revenue of $1.97 billion.Samsara shares fell 3.2% in after-hours trading.

$IOT